Incisional infections and wound dehiscence within 30 days of surgery · people with inflammatory bowel disease
It is very uncertain whether risk of postoperative infectious complications: corticosteroids changes incisional infections and wound dehiscence within 30 days of surgery compared with control (very low certainty).
1 finding from 1 review
Intra‐abdominal infectious complications within 30 days of surgery · people with inflammatory bowel disease
It is very uncertain whether risk of postoperative infectious complications: corticosteroids changes intra‐abdominal infectious complications within 30 days of surgery compared with control (very low certainty).
1 finding from 1 review
Extra‐abdominal infections within 30 days of surgery · people with inflammatory bowel disease
It is very uncertain whether risk of postoperative infectious complications: corticosteroids changes extra‐abdominal infections within 30 days of surgery compared with control (very low certainty).
1 finding from 1 review
Infectious complications · people with inflammatory bowel disease
It is very uncertain whether risk of postoperative infectious complications: 5‐ASA changes overall infectious complications within 30 days of surgery compared with control (very low certainty).
3 findings from 1 review
OR 0.76 [0.51, 1.14]
6 studies · 6 participants
Very low
no estimate extracted
0 studies · 0 participants
GRADE not reported
OR 0.76 [0.51, 1.14]
6 studies · 6 participants
Very low
Intervention not reported
Minimally invasive step‐up approach: planned surgery vs. continued percutaneous drainage · people with necrotising pancreatitis
It is very uncertain whether the intervention changes minimally invasive step‐up approach: planned surgery vs. continued… (very low certainty).
1 finding from 1 review
OR 21 [0.64, 689.99]
1 study · 8 participants
Very low
Long‐term mortality (time‐to‐event outcome): chemoradiotherapy versus surgery All‐cause mortality for the duration of · patients with oesophageal cancer
Non‐surgical showed no clear difference in long‐term mortality (time‐to‐event outcome): chemoradiotherapy… compared with surgical treatment of oesophageal cancer (primary outcomes) (low certainty).
2 findings from 1 review
Long‐term mortality (time‐to‐event outcome): radiotherapy versus surgery All‐cause mortality for the duration of · patients with oesophageal cancer
It is very uncertain whether non‐surgical changes long‐term mortality (time‐to‐event outcome): radiotherapy versus… compared with surgical treatment of oesophageal cancer (primary outcomes) (very low certainty).
1 finding from 1 review
Long‐term mortality (binary outcome) All‐cause mortality for the duration of · patients with oesophageal cancer
Non‐surgical showed no clear difference in long‐term mortality (binary): definitive chemoradiotherapy versus… compared with surgical treatment of oesophageal cancer (primary outcomes) (low certainty).
1 finding from 1 review
Intervention not reported
Postoperative mortality (within 30 days from surgery) · patients with resectable disease
1 finding from 1 review
Intervention not reported
Postoperative mortality (within 30 days from surgery) · patients with resectable disease
The intervention leads to higher postoperative mortality (within 30 days from surgery) (high certainty).
1 finding from 1 review
Surgery rate Number requiring emergency surgery · patients with high‐risk bleeding ulcers
Epinephrine probably leads to lower surgery rate Number requiring emergency surgery compared with epinephrine and any second endoscopic method (moderate certainty).
1 finding from 1 review
Surgery Number of participants who underwent surgery · patients with upper gastrointestinal bleeding
Tranexamic acid probably leads to lower surgery Number of participants who underwent surgery compared with placebo (moderate certainty).
1 finding from 1 review
Surgery Number of participants who underwent surgery · patients with upper gastrointestinal bleeding
Tranexamic acid probably leads to lower surgery Number of participants who underwent surgery compared with cimetidine or lansoprazole (moderate certainty).
1 finding from 1 review
Surgery · patients with acute peptic ulcer bleeding
High showed no clear difference in surgery compared with non‐high (medium or low) dose regimen (low certainty).
1 finding from 1 review
All‐cause mortality · people undergoing elective pancreatic resections
Drain use showed no clear difference in mortality compared with no drain use following pancreatic surgery (low certainty).
2 findings from 1 review
Intra‐abdominal infection · people undergoing elective pancreatic resections
It is very uncertain whether active drain changes intra‐abdominal infection compared with passive drain following pancreatic surgery (very low certainty).
1 finding from 1 review
Wound infection · people undergoing elective pancreatic resections
It is very uncertain whether active drain changes wound infection compared with passive drain following pancreatic surgery (very low certainty).
1 finding from 1 review
Drain‐related complications · people undergoing elective pancreatic resections
1 finding from 1 review
Morbidity · people undergoing elective pancreatic resections
It is very uncertain whether active drain changes morbidity compared with passive drain following pancreatic surgery (very low certainty).
1 finding from 1 review
Length of hospital stay · people undergoing elective pancreatic resections
It is very uncertain whether active drain changes length of hospital stay compared with passive drain following pancreatic surgery (very low certainty).
1 finding from 1 review